Cannabix Technologies Inc development of the Cannabix marijuana breathalyzer... Show more
On August 08, 2025, the Stochastic Oscillator for BLOZF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 77 instances where the indicator left the oversold zone. In of the 77 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The Moving Average Convergence Divergence (MACD) for BLOZF just turned positive on August 21, 2025. Looking at past instances where BLOZF's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BLOZF advanced for three days, in of 204 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on August 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BLOZF as a result. In of 111 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
BLOZF moved below its 50-day moving average on July 25, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BLOZF crossed bearishly below the 50-day moving average on July 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLOZF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BLOZF entered a downward trend on July 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.883) is normal, around the industry mean (59.985). P/E Ratio (0.000) is within average values for comparable stocks, (38.906). BLOZF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.722). BLOZF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.020). P/S Ratio (0.000) is also within normal values, averaging (79.264).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BLOZF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLOZF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry MedicalNursingServices
A.I.dvisor tells us that BLOZF and PXMBF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BLOZF and PXMBF's prices will move in lockstep.
Ticker / NAME | Correlation To BLOZF | 1D Price Change % | ||
---|---|---|---|---|
BLOZF | 100% | +0.48% | ||
PXMBF - BLOZF | 24% Poorly correlated | N/A | ||
NUWE - BLOZF | 22% Poorly correlated | -3.64% | ||
ANPCF - BLOZF | 21% Poorly correlated | N/A | ||
BRSYF - BLOZF | 4% Poorly correlated | N/A | ||
BBLG - BLOZF | 4% Poorly correlated | -2.25% | ||
More |
Ticker / NAME | Correlation To BLOZF | 1D Price Change % |
---|---|---|
BLOZF | 100% | +0.48% |
Health Services category (437 stocks) | 2% Poorly correlated | +0.79% |
Medical/Nursing Services category (225 stocks) | 0% Poorly correlated | +1.40% |